Skip to main content

Grafa News and Videos — Page 1186

Latest

Grafa
Technology

Colliers completes acquisition of Spain’s Ayesa Engineering to expand global footprint

Colliers (NASDAQ:CIGI) has officially closed its acquisition of Ayesa Engineering, the engineering division of the Seville-based Ayesa Group, marking a significant expansion of the global real estate and investment management firm's technical capabilities.

Read more: Colliers completes acquisition of Spain’s Ayesa Engineering to expand global footprint
Grafa

Gilead posts long-term data showing sustained liver marker normalization with Livdelzi

Gilead Sciences (NASDAQ:GILD) released new results from a post hoc analysis of its open-label Phase 3 ASSURE study, demonstrating that its approved drug Livdelzi (seladelpar) achieved high and sustained rates of normalization in a key biomarker of liver disease progression.

Read more: Gilead posts long-term data showing sustained liver marker normalization with Livdelzi
Grafa

Precision BioSciences posts first patient biopsy data proving Hepatitis B viral elimination

Precision BioSciences (NASDAQ:DTIL) unveiled late-breaking clinical data from its ongoing Phase 1/2a ELIMINATE-B trial, delivering what it characterizes as the first-ever human biopsy evidence of a therapeutic agent successfully eliminating and inactivating the root genetic reservoir of chronic hepatitis B.

Read more: Precision BioSciences posts first patient biopsy data proving Hepatitis B viral elimination

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift